Hazardous alcohol use is highly prevalent among adults with chronic pain. Although there is reason to believe that perceptions about the relationships between pain and alcohol use are important for understanding, predicting, and intervening upon alcohol use behavior, no prior work has explored such perceptions or their association with hazardous drinking. Among 273 adults who reported chronic pain and alcohol consumption (Mage = 33), we examined the relationship between perceptions regarding pain and alcohol use and indices of hazardous alcohol behaviors. Participants indicated the extent to which they held perceptions that (1) pain can be a motivator of alcohol consumption, (2) alcohol consumption can help one cope with pain, and (3) pain can be a barrier to quitting drinking. Alcohol use was assessed using the Alcohol Use Disorders Identification Test, which includes three indices of hazardous drinking: alcohol consumption, harmful drinking, and alcohol dependence. Perceptions about pain and alcohol accounted for 16-19% of the variance in alcohol consumption, harmful drinking, and alcohol dependence (ps < 0.008). Specifically, perceptions that alcohol can help one cope with pain were positively associated with alcohol consumption and harmful drinking. Perceptions that pain can be a barrier to alcohol reduction were positively associated with alcohol dependence and harmful drinking. This is the first study to examine relationships between perceptions about pain and alcohol use and hazardous drinking. Findings contribute to a growing literature suggesting that perceptions about the interrelations between pain and substance use may contribute to hazardous patterns of use.
Tobacco use is a significant national health concern that frequently co-occurs with chronic pain. Both pain and use of nicotine/tobacco have been linked to greater sleep impairments (i.e., trouble initiating and maintaining sleep), and there is reason to believe that more severe pain may indirectly contribute to greater nicotine dependence via sleep impairments. Therefore, the goal of this study was to examine indirect associations between pain severity and nicotine dependence via sleep impairment severity among adults who use cigarettes and electronic nicotine delivery systems (ENDS). Data were drawn from Wave 6 (March - November 2021) of the Population Assessment of Tobacco and Health Study (PATH), limited to N = 9,682 (54% male; 22% ages 25-24; 77% White) participants who reported regular cigarette smoking and/or ENDS use. Pain severity and sleep impairment were assessed using single items, and nicotine/tobacco dependence was assessed using the Wisconsin Inventory of Smoking Dependence Motives (WISDM). Results indicated positive indirect associations between pain severity and both tobacco and ENDS dependence via sleep impairment severity. Sleep impairment may play an important role in associations between pain severity and nicotine dependence among adults who use cigarettes or ENDS. These findings and future work may warrant the development of interventions that address sleep dysfunction to support nicotine and tobacco cessation, particularly among adults who experience pain.
13 July 2025 in The American Journal on Addictions
Background and Objectives: Chronic pain and alcohol use are highly prevalent and frequently co‐occur among U.S. military veterans. Expectancies for alcohol analgesia (i.e., degree to which one believes that drinking can reduce or manage pain) may contribute to alcohol consumption, dependence, and related harms. Discrimination in medical settings (i.e., inequitable treatment in healthcare contexts) has been linked to deleterious health outcomes and may amplify associations between expectancies for alcohol analgesia and indices of hazardous drinking. Our goal was to test discrimination in medical settings as a moderator of associations between expectancies for alcohol analgesia and drinking behavior. Methods: Participants included 430 U.S. military veterans with chronic pain and past month alcohol consumption (24% female; 73% White; Mage = 57) who completed an online survey via Qualtrics Panels. Results: Expectancies for alcohol analgesia were positively associated with alcohol consumption, dependence, and related harms. Discrimination in medical settings moderated associations between expectancies for alcohol analgesia and alcohol consumption and dependence. Discussion and Conclusions: Among veterans with pain, expectancies for alcohol analgesia were positively associated with indices of hazardous drinking, and discrimination in medical settings moderated associations between expectancies for alcohol analgesia and alcohol consumption and dependence. Future research should explore the potential utility of interventions addressing expectancies for alcohol analgesia and discrimination in medical settings in the context of pain and drinking. Scientific Significance: These findings are the first to demonstrate that experiences of discrimination in healthcare contexts amplify relations between expectancies for alcohol analgesia and drinking behavior among veterans with pain.
Although cannabis has gained attention as a potential treatment for chronic pain, hazardous cannabis use (i.e. patterns of use that have harmful consequences) has been linked to negative health outcomes. Pain intensity is associated with greater cannabis use, and individuals with greater pain-related anxiety may be more likely to respond to pain with substance use. However, no prior work has examined the role of pain-related anxiety in hazardous cannabis use among individuals with chronic pain. The current analyses tested whether pain-related anxiety moderates associations between pain intensity and hazardous cannabis use. Participants included 80 cannabis users with chronic pain (63% male; 67% White; Mage = 33.6). Results indicated a positive interaction between pain intensity and pain-related anxiety on hazardous cannabis use (p < .05), such that pain intensity was positively associated with hazardous cannabis use among individuals with moderate and high pain-related anxiety, but not those with low pain-related anxiety, suggesting that pain-related anxiety may function as a transdiagnostic vulnerability factor for greater co-occurring pain and hazardous cannabis use. Future work should examine longitudinal associations between pain, pain-related anxiety, and hazardous cannabis use. There may be clinical utility in addressing pain-related anxiety among cannabis users with chronic pain.
2 January 2026 in The American Journal of Drug and Alcohol Abuse
Background: Prescription opioid misuse (i.e. use without a prescription or in ways other than prescribed) is a significant health concern among individuals with chronic pain. Hazardous alcohol use (i.e. drinking that increases risk of negative consequences) is common among individuals with pain, including among those who are prescribed opioids. Everyday discrimination, which is characterized by interpersonal experiences of identity-based harassment, has been independently linked to both depressive symptoms and prescription opioid misuse. Although promising as a potentially modifiable intervention target, the mediating role of depressive symptoms in associations between everyday discrimination and prescription opioid misuse remain largely unexplored. Further, it is important to identify factors associated with prescription opioid misuse among individuals with chronic pain who engage in hazardous alcohol use, as both are positively associated with prescription opioid misuse.Objectives: To examine indirect associations between everyday discrimination and prescription opioid misuse via depressive symptoms among adults with chronic pain who engage in hazardous drinking.Methods: Participants included 150 adults with pain (35.7% Black/African American; 59.7% female; Mage = 44.27) who were prescribed opioids and drank hazardously.Results: A process model revealed that depressive symptoms acted as mediator of associationsbetween everyday discrimination and prescription opioid misuse (b = 0.26, bootstrapped 95% CI [0.15, 0.39]). Specifically, everyday discrimination was associated with greater depressive symptoms, which in turn was associated with greater prescription opioid misuse.Conclusion: These findings suggest that providers should screen for depressive symptoms in the context of prescription opioid misuse, particularly among individuals who experience discrimination.
U.S. military veterans face an elevated suicide risk compared to the general population. Both the use and misuse of tranquilizers (i.e. several classes of medications that treat anxiety and muscle spasms via central nervous system action, including benzodiazepines) have been associated with suicidal thoughts and behaviors among veterans. However, it remains unclear whether risk varies across different patterns of tranquilizer use. Participants included 12,584 U.S. military veterans (13.0% female; 78.1% non-Hispanic White; 49.3% age 65 and older), from the 2015-2019 National Survey on Drug Use and Health (NSDUH). Tranquilizer use without misuse was associated with greater odds of suicidal ideation and planning, relative to nonuse (p's < 0.01). Tranquilizer misuse was associated with greater odds of suicide ideation, planning, and attempts compared to nonuse (p's < 0.01). Relative to use without misuse, tranquilizer misuse was associated with greater odds of suicide ideation, planning, and attempts (p's < 0.01). These results support a graded association between tranquilizer use/misuse and suicidal thoughts and behaviors, suggesting that risk for suicide-related outcomes may increase from no use, to use without misuse, to misuse. Future research should explore the clinical utility of addressing tranquilizer use/misuse as part of targeted suicide prevention strategies among veterans.